Table 3. Clinical characteristics of the included studies.
| Study | Clinical response | Number of RFA sessions | Number of RFA application/session | Adverse events | Surgery | Device | Follow-up (months) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Acute pancreatitis | Pancreatic duct stenosis | Perforation | Peripancreatic fluid collection | Ascites | |||||||
| Barthet 2019 | 24/31 | 31 | Not reported | 3 | 1 | 1 | 1 | 0 | 0 | 1 | Starmed | 6–12 (range) |
| Choi 2018 | 7/10 | 16 | 4.6 (mean) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | Starmed | 13 (median) |
| Crino 2018 | 8/8 | 8 | 1.5 (mean) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Starmed | 1–8 (range) |
| Oleinikov 2019 | 26/27 | 27 | Not reported | 2 | 2 | 0 | 0 | 0 | 0 | 0 | Starmed | 9.7 (mean) |
| Pai 2015 | 7/8 | 9 | 4.5 (median) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Habib | 3–6 (range) |
| Scopelliti 2018 | 10/10 | 10 | 1.4 (mean) | 4 | 0 | 0 | 0 | 2 | 2 | 0 | Starmed | 1 |
| Song 2016 | 6/6 | 8 | 1.3 (mean) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Starmed | 3–6 (range) |
| Dancour 2019 | 8/8 | 8 | 6 (mean) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Habib | 9.25 (median) |
| Yang 2019 | 8/8 | 8 | Not reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Habib | 12 (mean) |
| De la Serna 2018 | 7/9 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Starmed | 8 (median) |
RFA, radiofrequency ablation.